DLK Investment Management, LLC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 2016793 SOLANA BEACH, CA

Position in HRTX

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$7,635

-$1,717 QoQ

Shares Held

17,890

+53.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 8 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

DLK Investment Management, LLC holds $164,280 across 4 Biotechnology names. HRTX ranks #4 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SPRO	Spero Therapeutics, Inc.	31,355	$69,294
2	EDIT	Editas Medicine, Inc.	17,702	$57,354
3	BDTX	Black Diamond Therapeutics, Inc.	16,215	$29,997
4	HRTX	Heron Therapeutics, Inc. /De/ This page	17,890	$7,635

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,635	17,890	+53.0%	Shares	Sole	2026-07-14
2026-03-31	$9,352	11,690	0.0%	Shares	Sole	2026-04-15
2025-12-31	$15,197	11,690	-47.3%	Shares	Sole	2026-01-14
2025-09-30	$27,959	22,190	+27.6%	Shares	Sole	2025-10-14
2025-06-30	$35,997	17,390	0.0%	Shares	Sole	2025-07-09
2025-03-31	$38,258	17,390	0.0%	Shares	Sole	2025-04-23
2024-12-31	$26,606	17,390	-2.8%	Shares	Sole	2025-01-16
2024-09-30	$35,601	17,890	0.0%	Shares	Sole	2024-10-09
2024-06-30	$62,615	17,890	0.0%	Shares	Sole	2024-08-05
2024-03-31	$49,555	17,890	0.0%	Shares	Sole	2024-04-12
2023-12-31	$30,413	17,890	—	Shares	Sole	2024-04-09
No filing history on record for this holder in this stock.